Navigation Links
Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
Date:5/15/2013

about Boehringer Ingelheim clinical trials in oncology can visit www.inoncologyus.com for additional information. 

About Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 140 affiliates and more than 46,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

As a central element of its culture, Boehringer Ingelheim has a demonstrated commitment to corporate social responsibility. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavors.

In 2012, Boehringer Ingelheim achieved net sales of about $19.1 billion (14.7 billion euro). R&D expenditure in the business area Prescription Medicines corresponds to 22.5% of its net sales.

For more information please visit www.us.boehringer-ingelheim.com.

*Afatinib and nintedanib are investigational compounds; their safety and efficacy have not been established.

References 

[1] Wu, Y., MD.  LUX-Lung 6: A randomized, open-label, Phase III study of afatinib (A) vs gemcitabine/cisplatin
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
10. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
11. Boehringer Ingelheim Announces Equine Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014  Alexza Pharmaceuticals, Inc. (Nasdaq: ... its pipeline and new product development efforts. In the ... a Phase 2a study of AZ-002 (Staccato ® ... management of patients with acute repetitive seizures.  Additionally, ... product candidates for development - AZ-008 and AZ-009 ...
(Date:7/31/2014)... Mass. , July 31, 2014  Decision Resources ... technology market intelligence product Marketrack to now include ChinaTrack; ... device landscape in an interactive dashboard providing detailed ... procedure volumes at a hospital level. Other ... , Updated data feed: In addition to end-user surveys ...
(Date:7/31/2014)... 2014 For its innovative modular Biomedical Research ... Art,s-Way Scientific has earned a Modular Building Institute (MBI) ... over 30 categories, MBI,s contest is the commercial modular ... building manufacturers, dealers, and product and service providers. ... capability of our team," said Dan Palmer , ...
Breaking Medicine Technology:Alexza Provides Pipeline Update 2Alexza Provides Pipeline Update 3Alexza Provides Pipeline Update 4Alexza Provides Pipeline Update 5Alexza Provides Pipeline Update 6Decision Resources Group Announces First Medical Device Account Targeting Tool in China 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4
... CYBX ) today announced that it will ... Moore, President and Chief Executive Officer, will present at ... on Tuesday, September 21, 2010 at 1:00 PM EDT. ... and by replay at http://cc.talkpoint.com/ubsx001/092110a_lv/?entity=66_7PVQHBG .  The conference ...
... Sept. 13 Xoft, Inc., the pioneer ... minimally-shielded clinical settings, today announced the introduction ... to physicians and distributors in Europe.  The ... to cancer sites with minimal radiation exposure ...
Cached Medicine Technology:Cyberonics to Participate in Upcoming September Investor Conferences 2Xoft Introduces Electronic Brachytherapy Cancer Treatment Platform at ESTRO Meeting 2Xoft Introduces Electronic Brachytherapy Cancer Treatment Platform at ESTRO Meeting 3
(Date:7/31/2014)... Women over the age of 65 face numerous ... greater struggles against poverty and higher rates of asthma ... August issue of Annals of Allergy, Asthma and ... of Allergy, Asthma and Immunology (ACAAI), outlines the challenges ... practical solutions to improve their care. , ...
(Date:7/31/2014)... August 01, 2014 The 2013 ... increasing 0.89 points from 75.07 in 2012. The ... tourism-related sectors and integrates them into an overall ... become increasingly more satisfied with Hong Kong over ... consistently excelling in service performance in Hong Kong ...
(Date:7/31/2014)... Ce-Classes.com has announced that they are now ... a Systematic Review of Sexual Satisfaction . ... International Journal of Clinical and Health Psychology. , This ... need to have accurate information about sexual satisfaction so ... The material provides a systematic review of 197 ...
(Date:7/31/2014)... In today’s world, a good night’s sleep has become especially ... (a medical problem where the airway collapses during sleep and ... rest they need to face their daily challenges. , ... people in the United States alone have sleep apnea. Of ... those treated, many cannot tolerate their prescribed medical device known ...
(Date:7/31/2014)... Vegas, NV (PRWEB) July 31, 2014 Weblify ... Mataka, after 4 years of development and testing. The ... perfectly monetized websites in as little as 5 minutes without ... full Weblify review , Shane Michaels, an SEO expert, ... very quickly. “I’ve seen a lot of web site ...
Breaking Medicine News(10 mins):Health News:Female baby boomers with asthma? You may need help 2Health News:Female baby boomers with asthma? You may need help 3Health News:PolyU Released Report On 2013 Tourist Satisfaction and Tourism Service Quality Indices to Boost Tourism Development 2Health News:PolyU Released Report On 2013 Tourist Satisfaction and Tourism Service Quality Indices to Boost Tourism Development 3Health News:Company Provides New Course on Sexual Satisfaction 2Health News:Company Provides New Course on Sexual Satisfaction 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 2Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 3
... In a major victory for California,s 250,000 In-Home ... people with disabilities who rely on IHSS for daily ... to the IHSS program violate the terms of the ... ruling came after the Service Employees International Union (SEIU) ...
... helps Michigan ,s economy DETROIT, ... Shield of Michigan is striving to further develop its ... to working to address the economic and health security ... Daniel J. Loepp said Thursday.As the keynote speaker on ...
... In his Fiscal Year 2010 (FY 10) budget request, President ... care by $107 million. In doing so, President Obama ... FY 10 budget outline of increasing "resources to detect, prevent, ... is good news for the U.S., especially for people living ...
... IRIDEX Corporation (Nasdaq: IRIX ) today announced that it ... closes on Thursday, May 14, 2009. ... call with the investment community at 5:00 p.m. Eastern ... to discuss the results of the quarter and other business ...
... 7 /PRNewswire/ -- John Fraser, a ... for the Hershey kisses that he and his United States ... "Battle of the Bulge."In a recent letter to the Hershey ... flew 35 missions over enemy territory. I got hit ...
... guidelines to help determine which patients need more ... While some heart patients can safely go home ... coronary intervention, or PCI), others may have to ... says an expert consensus statement released Thursday. , ...
Cached Medicine News:Health News:Obama Administration Rules Against California's Proposed Wage Cuts to Homecare Workers 2Health News:Michigan Blues' CEO Daniel J. Loepp Reinforces Company's Commitment to Minority Business Partners 2Health News:AIDS Action Welcomes President's Budget Increases Yet Expresses Distress With Failure to End Federal Ban on Syringe Exchange Funding 2Health News:AIDS Action Welcomes President's Budget Increases Yet Expresses Distress With Failure to End Federal Ban on Syringe Exchange Funding 3Health News:World War II Air Force Veteran Remembers 'Kisses' Sweeter Than Wine 2Health News:Discharge Time After Angioplasty Varies 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: